These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31959384)

  • 1. Corrigendum to "Huachansu capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway" [Biomed. Pharmacother. 118 (2019) 109241].
    Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
    Biomed Pharmacother; 2020 Mar; 123():109823. PubMed ID: 31959384
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to 'Jinlong Capsule (JLC) inhibits proliferation and induces apoptosis in human gastric cancer cells in vivo and in vitro' Biomed. Pharmacother. 107 (2018) 738-745.
    Li D; Ni T; Tao L; Jin F; Wang H; Feng J; Zhu G; Qian Y; Ding Y; Sunagagwa M; Liu Y
    Biomed Pharmacother; 2023 Oct; 166():115211. PubMed ID: 37573185
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes" [Biomed. Pharmacother. 126 (2020) 110066].
    Li X; Shang D; Shen H; Song J; Hao G; Tian Y
    Biomed Pharmacother; 2020 Oct; 130():110858. PubMed ID: 33054976
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Saikosaponin A inhibits the activation of pancreatic stellate cells by suppressing autophagy and the NLRP3 inflammasome via the AMPK/mTOR pathway" [Biomed. Pharmacother. 128 (2020) 110216].
    Cui L; Li C; Zhuo Y; Yang L; Cui N; Li Y; Zhang S
    Biomed Pharmacother; 2020 Oct; 130():110685. PubMed ID: 32893050
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1/CD147/MMPs pathway" [Biomed. Pharmacother. 84 (2016) 1776-1782].
    Yuan S; Wang L; Chen X; Fan B; Yuan Q; Zhang H; Yang D; Wang S
    Biomed Pharmacother; 2020 Feb; 122():109782. PubMed ID: 31862132
    [No Abstract]   [Full Text] [Related]  

  • 6. 'Corrigendum to "Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal carcinoma cells" [Biomed. Pharmacother. 98 (2018) 36-44]'.
    Zhao Y; Tang H; Zeng X; Ye D; Liu J
    Biomed Pharmacother; 2022 Sep; 153():113329. PubMed ID: 35760645
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Cerebral dopamine neurotrophic factor protects microglia by combining with AKT and by regulating FoxO1/mTOR signaling during neuroinflammation" [Biomed. Pharmacother. 109 (2018) 2278-2284].
    Zhang Y; Xiang Y; Wang X; Zhu L; Li H; Wang S; Pan X; Zhao H
    Biomed Pharmacother; 2019 Apr; 112():108548. PubMed ID: 30773235
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "MiR-337-3p promotes chondrocytes proliferation and inhibits apoptosis by regulating PTEN/AKT axis in osteoarthritis" [Biomed. Pharmacother. 95 (2017) 1194-1200].
    Huang Z; Zhang N; Ma W; Dai X; Liu J
    Biomed Pharmacother; 2022 Sep; 153():113497. PubMed ID: 35948468
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration" [Biomed. Pharmacother. 128 (2020) 110366].
    Guo Y; Zhu H; Weng M; Chen B; Wang C; Sun L
    Biomed Pharmacother; 2020 Sep; 129():110394. PubMed ID: 32561180
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration" [Biomed. Pharmacother. 2020 (128) 110366].
    Guo Y; Zhu H; Weng M; Chen B; Wang C; Sun L
    Biomed Pharmacother; 2020 Oct; 130():110631. PubMed ID: 32828598
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to 'Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway' [Biomed. Pharmacother. 90 (2017) 437-445].
    Zheng G; Shen Z; Chen H; Liu J; Jiang K; Fan L; Jia L; Shao J
    Biomed Pharmacother; 2018 Feb; 98():925-926. PubMed ID: 29421862
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Cytoprotective effect of Fufang Lurong Jiangu capsule against hydrogen peroxide-induced oxidative stress in bone marrow stromal cell-derived osteoblasts through the Nrf2/HO-1 signaling pathway" [Biomed. Pharmacother. 121 (2020) 109676].
    Jin W; Zhu X; Yao F; Xu X; Chen X; Luo Z; Zhao D; Li X; Leng X; Sun L
    Biomed Pharmacother; 2020 Feb; 122():109808. PubMed ID: 31902541
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway" [Biomed. Pharmacother. 118 (2019) 109111].
    Wan W; Wan W; Long Y; Li Q; Jin X; Wan G; Zhang F; Lv Y; Zheng G; Li Z; Zhu Y
    Biomed Pharmacother; 2020 Nov; 131():110842. PubMed ID: 33092949
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Folate inhibits miR-27a-3p expression during cervical carcinoma progression and oncogenic activity in human cervical cancer cells" [Biomed. Pharmacother. 122 (2020) 109654].
    Wang Z; Wang W; Zhao W; Wang Z; Yang J; Wang W; Teng P; Su X; Li D; Zhang X; Wang H; Hao M
    Biomed Pharmacother; 2020 May; 125():109981. PubMed ID: 32067843
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity" [Biomed. Pharmacother. 105 (2018) 758-765].
    Qin J; Shi H; Xu Y; Zhao F; Wang Q
    Biomed Pharmacother; 2019 Oct; 118():109107. PubMed ID: 31227337
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion" [Biomed. Pharmacother. 82 (2016) 319-326].
    Ye T; Zhu S; Zhu Y; Feng Q; He B; Xiong Y; Zhao L; Zhang Y; Yu L; Yang L
    Biomed Pharmacother; 2019 Dec; 120():109510. PubMed ID: 31635901
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway" [Biomed. Pharmacother. 115 (2019) 108922].
    Xu X; Rajamanicham V; Xu S; Liu Z; Yan T; Liang G; Guo G; Zhou H; Wang Y
    Biomed Pharmacother; 2022 May; 149():112865. PubMed ID: 35367116
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo" [Biomed. Pharmacother. 116 (2019) 109032].
    Weng MC; Li MH; Chung JG; Liu YC; Jeng-Yuan W; Hsu FT; Wang HE
    Biomed Pharmacother; 2019 Oct; 118():109209. PubMed ID: 31324388
    [No Abstract]   [Full Text] [Related]  

  • 19. Retraction notice to "Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway" [Biomed. Pharmacother. 107 (2018) 185-193].
    Cao B; Liu C; Yang G
    Biomed Pharmacother; 2021 Oct; 142():112116. PubMed ID: 34509335
    [No Abstract]   [Full Text] [Related]  

  • 20. Mefloquine effectively targets gastric cancer cells through phosphatase-dependent inhibition of PI3K/Akt/mTOR signaling pathway.
    Liu Y; Chen S; Xue R; Zhao J; Di M
    Biochem Biophys Res Commun; 2016 Feb; 470(2):350-355. PubMed ID: 26780727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.